These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35876085)

  • 21. Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practice.
    Przybylski DJ; Dow-Hillgartner EN; Reed MP; Fallon MJ
    J Oncol Pharm Pract; 2020 Sep; 26(6):1374-1381. PubMed ID: 31937189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models.
    Hayward J; McDermott J; Qureshi N; Newman W
    Pharmacogenomics; 2021 Aug; 22(12):761-776. PubMed ID: 34467776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals.
    Pearce A; Terrill B; Alffenaar JW; Patanwala AE; Kummerfeld S; Day R; Young MA; Stocker SL
    Intern Med J; 2022 Jul; 52(7):1135-1143. PubMed ID: 35191159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of the Pediatric Pharmacist in Precision Medicine and Clinical Pharmacogenomics for Children.
    Brown JT; Gregornik D; Kennedy MJ;
    J Pediatr Pharmacol Ther; 2018; 23(6):499-501. PubMed ID: 30697138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
    Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
    Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenomics in Pain Management: A Review of Relevant Gene-Drug Associations and Clinical Considerations.
    Brandl E; Halford Z; Clark MD; Herndon C
    Ann Pharmacother; 2021 Dec; 55(12):1486-1501. PubMed ID: 33771051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Awareness regarding clinical application of pharmacogenetics among Japanese pharmacists.
    Obara T; Abe S; Satoh M; Gutiérrez Ubeda SR; Yoshimachi S; Goto T
    Pharmgenomics Pers Med; 2015; 8():35-41. PubMed ID: 25691815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and evaluation of a pharmacogenomics information resource for pharmacists.
    Romagnoli KM; Boyce RD; Empey PE; Ning Y; Adams S; Hochheiser H
    J Am Med Inform Assoc; 2017 Jul; 24(4):822-831. PubMed ID: 28339805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding pharmacogenomic testing and its role in medicine prescribing.
    Youssef E; Buck J; Wright DJ
    Nurs Stand; 2020 Jul; 35(7):55-60. PubMed ID: 32524796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Trial Designs to Support Clinical Utility of Pharmacogenomic Testing.
    Drozda K; Pacanowski MA
    Pharmacotherapy; 2017 Sep; 37(9):1000-1004. PubMed ID: 28605049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient perspectives following pharmacogenomics results disclosure in an integrated health system.
    Lemke AA; Hulick PJ; Wake DT; Wang C; Sereika AW; Yu KD; Glaser NS; Dunnenberger HM
    Pharmacogenomics; 2018 Mar; 19(4):321-331. PubMed ID: 29469671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient perceptions of pharmacogenomic testing in the community pharmacy setting.
    Bright D; Worley M; Porter BL
    Res Social Adm Pharm; 2021 Apr; 17(4):744-749. PubMed ID: 32741696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and educational impact of pharmacogenomics testing: a case series from the INGENIOUS trial.
    Pierson RC; Gufford BT; Desta Z; Eadon MT
    Pharmacogenomics; 2017 Jun; 18(9):835-841. PubMed ID: 28594278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are pharmacists from the province of Quebec ready to integrate pharmacogenetics into their practice.
    Petit C; Croisetière A; Chen F; Laverdière I
    Pharmacogenomics; 2020 Mar; 21(4):247-256. PubMed ID: 32180495
    [No Abstract]   [Full Text] [Related]  

  • 37. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating pharmacogenomics into electronic health records with clinical decision support.
    Hicks JK; Dunnenberger HM; Gumpper KF; Haidar CE; Hoffman JM
    Am J Health Syst Pharm; 2016 Dec; 73(23):1967-1976. PubMed ID: 27864204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to assess pharmacogenomic tests for implementation in the NHS in England.
    Sanghvi S; Ferner RE; Scourfield A; Urquhart R; Amin S; Hingorani AD; Sofat R
    Br J Clin Pharmacol; 2023 Sep; 89(9):2649-2657. PubMed ID: 37313748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study.
    Papastergiou J; Tolios P; Li W; Li J
    J Am Pharm Assoc (2003); 2017; 57(5):624-629. PubMed ID: 28689706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.